drugset / Trial / NCT01817803

A Prospective, Single-center, Open-label, Pilot Study to Compare the Effectiveness and Safety of Diuretics Add-On Strategy in Chronic Heart Failure Patients (DIOS 1)

NCT01817803

Withdrawn Yonsei University
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the effectiveness and safety of diuretics add-on strategy in chronic heart failure patients

Timeline

Start
2013-03
Primary completion
2015-06
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Furosemide Other / unclassified
Comparator Metolazone Small molecule 2.5 mg
Comparator Spironolactone Small molecule 12.5 mg